Tokyo:4597

Alcami Announces Manufacturing Agreement for Solasia's Active Pharmaceutical Ingredient Darinaparsin

DURHAM, North Carolina, Nov. 9, 2017 /PRNewswire/ -- Alcami, a leading provider of custom end-to-end development and manufacturing services for the pharmaceutical and biotechnology industries, today announces it has finalized manufacturing and quality agreements with Solasia Pharma, K.K. (TSE: 45...

2017-11-09 23:00 2107